Treatment

Breakthrough Rice Bran Nanoparticles Show Promise as Affordable and Targeted Anticancer Agent

Researchers discover that nanoparticles derived from rice bran are both effective and safe for the treatment of cancer Several types…

7 months ago

Advances In Cancer Treatments

Introduction This article delves into the most advanced and effective cancer treatment options currently available. It provides an in-depth analysis…

8 months ago

MHRA Grants ADvantage Therapeutics Innovative Licensing and Access Pathway (ILAP) Designation for Novel Lead Product AD04™ for Phase 2b Trial in Alzheimer’s Disease

ILAP Designation accelerates patient access and commercialization  MIAMI, APRIL 5, 2023 (GLOBE NEWSWIRE) – ADvantage Therapeutics, Inc. (“ADvantage” or “the…

2 years ago

Novel Target-Specific Nanoparticles for Diagnosis and Treatment of Pancreatic Cancer

By Dr. Jill Smith Pancreatic cancer is well known as one of the deadliest cancers, with a paltry 11% survival…

2 years ago

Natural VS Safe Ingredients: What Matters When it Comes to Our Beauty Products?

By Michael Ambacher We all want to look and feel our best – but finding the right products to support…

2 years ago

Treating Alzheimer’s: Is It Really an Autoimmune Disease?

Although Alzheimer’s is still listed as an incurable neurodegenerative disease, medical science has come a long way in terms of…

2 years ago

Dysphagia From a Medical Standpoint

Dysphagia is an umbrella term which doctors use to describe difficulty swallowing. This is not the same as pain whilst…

2 years ago

CureVac Expands Lead RNA Cancer Program Phase 1 Trial in Advanced Melanoma

CV8102 recommended dose identified; expansion trial to confirm safety, tolerability, and efficacy Trial expansion focuses on advanced melanoma, an indication of…

4 years ago

Innovative Product ExoFlo™ Fulfills Unmet but Urgent Medical Need in COVID-19 Treatment

Medical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) Treatment…

4 years ago

Pharnext and the University Hospital Institute Méditerranée Infection Announce a Joint Effort to Evaluate Repurposed Drugs for Potential Use Against the COVID-19 Virus

Rapid in vitro testing of repurposed drug candidates identified by Pharnext's PLEOTHERAPYTM Artificial Intelligence platformPARIS, France, 8:00am, April 22, 2020 (CET) - Pharnext SA…

5 years ago